Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 67080M103 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Perceptive Advisors LLC
13G
|
5.3% |
9/23/2026
Event 9/16/2026
|
|
| Perceptive Advisors LLC | 5.3% | ||
| Joseph Edelman | 5.3% | ||
| Perceptive Life Sciences Master Fund, Ltd. | 5.3% | ||
|
Deep Track Capital, LP
13G/A
Amendment 3
|
7.5% |
8/14/2026
Event 6/30/2026
|
|
| Deep Track Capital, LP | 7.5% | ||
| Deep Track Biotechnology Master Fund, Ltd. | 7.5% | ||
| David Kroin | 7.5% | ||
|
Redmile Group, LLC
13G/A
Amendment 6
|
8.1%
Checked 5% or less
|
8/14/2026
Event 6/30/2026
|
|
| Redmile Group, LLC | 8.1% | ||
| Jeremy C. Green | 8.1% | ||
| RedCo II Offshore SPV LLC | 3.5% | ||
|
Rubric Capital Management LP
13G
|
7.0% |
8/14/2026
Event 6/30/2026
|
|
| Rubric Capital Management LP | 7.0% | ||
| David Rosen | 7.0% | ||
|
Vestal Point Capital, LP
13G/A
Amendment 1
|
7.8% |
8/14/2026
Event 6/30/2026
|
|
| Vestal Point Capital, LP | 7.8% | ||
| Ryan Wilder | 7.8% | ||
| Price T Rowe Associates Inc /MD/ 13G | 5.3% |
8/14/2026
Event 6/30/2026
|
|
| Vanguard Capital Management LLC 13G | 5.0% |
7/31/2026
Event 6/30/2026
|
|
|
Deep Track Capital, LP
13G/A
Amendment 2
|
6.2% |
5/15/2026
Event 3/31/2026
|
|
| Deep Track Capital, LP | 6.2% | ||
| Deep Track Biotechnology Master Fund, Ltd. | 6.2% | ||
| David Kroin | 6.2% | ||
|
Vestal Point Capital, LP
13G
|
6.3% |
5/15/2026
Event 3/31/2026
|
|
| Vestal Point Capital, LP | 6.3% | ||
| Ryan Wilder | 6.3% | ||
|
FMR LLC
13G
|
5.4% |
5/6/2026
Event 3/31/2026
|
|
| FMR LLC | 5.4% | ||
| Abigail P. Johnson | 5.4% | ||
|
Redmile Group, LLC
13G/A
Amendment 5
|
9.9%
Checked 5% or less
|
4/24/2026
Event 4/20/2026
|
|
| Redmile Group, LLC | 9.9% | ||
| Jeremy C. Green | 9.9% | ||
| RedCo II Offshore SPV LLC | 5.6% | ||
| RedCo II Master Fund, L.P. | 0% | ||
| Vanguard Group Inc 13G/A Amendment 1 | 0% |
3/27/2026
Event 3/13/2026
|
|
|
Baker Bros. Advisors LP
13G/A
Amendment 4
|
7.2% |
2/17/2026
Event 12/31/2025
|
|
| Baker Bros. Advisors LP | 7.2% | ||
| Baker Bros. Advisors (GP) LLC | 7.2% | ||
| Julian C. Baker | 7.2% | ||
| Felix J. Baker | 7.2% | ||
|
Commodore Capital LP
13G/A
Amendment 1
|
4.9% |
11/14/2025
Event 9/30/2025
|
|
| Commodore Capital LP | 4.9% | ||
| Commodore Capital Master LP | 4.9% | ||
|
FMR LLC
13G/A
Amendment 3
|
4.1% |
11/7/2025
Event 10/31/2025
|
|
| FMR LLC | 4.1% | ||
| Abigail P. Johnson | 4.1% | ||
|
FMR LLC
13G/A
Amendment 2
|
11.5% |
11/5/2025
Event 9/30/2025
|
|
| FMR LLC | 11.5% | ||
| Abigail P. Johnson | 11.5% | ||
|
Deep Track Capital, LP
13G/A
Amendment 1
|
7.2% |
5/15/2025
Event 3/31/2025
|
|
| Deep Track Capital, LP | 7.2% | ||
| Deep Track Biotechnology Master Fund, Ltd. | 7.2% | ||
| David Kroin | 7.2% | ||
|
Wellington Management Group LLP
13G/A
Amendment 1
|
4.2% |
5/12/2025
Event 3/31/2025
|
|
| Wellington Management Group LLP | 4.2% | ||
| Wellington Group Holdings LLP | 4.2% | ||
| Wellington Investment Advisors Holdings LLP | 4.2% | ||
|
FMR LLC
13G/A
Amendment 1
|
13.4% |
5/12/2025
Event 3/31/2025
|
|
| FMR LLC | 13.4% | ||
| Abigail P. Johnson | 13.4% | ||
| BlackRock, Inc. 13G/A Amendment 4 | 8.2% |
4/23/2025
Event 3/31/2025
|
|
|
Commodore Capital LP
13G
|
5.1% |
2/14/2025
Event 2/7/2025
|
|
| Commodore Capital LP | 5.1% | ||
| Commodore Capital Master LP | 5.1% | ||
|
Deep Track Capital, LP
13G
|
5.4% |
2/14/2025
Event 2/7/2025
|
|
| Deep Track Capital, LP | 5.4% | ||
| Deep Track Biotechnology Master Fund, Ltd. | 5.4% | ||
| David Kroin | 5.4% | ||
|
Deep Track Capital, LP
13G/A
Amendment 2
|
4.2% |
2/14/2025
Event 12/31/2024
|
|
| Deep Track Capital, LP | 4.2% | ||
| Deep Track Biotechnology Master Fund, Ltd. | 4.2% | ||
| David Kroin | 4.2% | ||
| ARK Investment Management LLC 13G/A Amendment 1 | 0% |
1/10/2025
Event 9/30/2024
|
|
|
FMR LLC
13G
|
14.5% |
12/6/2024
Event 11/29/2024
|
|
| FMR LLC | 14.5% | ||
| Abigail P. Johnson | 14.5% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 4 | 5.42 k | $128 k |
| 2026 Q2 | 220 | 119 M | $2.91 B |
| 2026 Q1 | 202 | 117 M | $1.82 B |
| 2025 Q4 | 191 | 114 M | $2.15 B |
| 2025 Q3 | 179 | 84.8 M | $784 M |
| 2025 Q2 | 170 | 88.4 M | $1.01 B |
| 2025 Q1 | 176 | 84.6 M | $1.01 B |
| 2024 Q4 | 182 | 81.1 M | $1.53 B |
| 2024 Q3 | 180 | 68.0 M | $1.53 B |
| 2024 Q2 | 184 | 67.0 M | $1.40 B |
| 2024 Q1 | 148 | 54.2 M | $796 M |
| 2023 Q4 | 137 | 49.5 M | $511 M |
| 2023 Q3 | 133 | 44.8 M | $352 M |
| 2023 Q2 | 132 | 43.6 M | $436 M |
| 2023 Q1 | 128 | 42.5 M | $377 M |
| 2022 Q4 | 126 | 45.2 M | $496 M |
| 2022 Q3 | 123 | 43.1 M | $561 M |
| 2022 Q2 | 111 | 45.3 M | $573 M |
| 2022 Q1 | 122 | 40.4 M | $567 M |
| 2021 Q4 | 129 | 40.5 M | $1.17 B |
| 2021 Q3 | 116 | 39.5 M | $1.18 B |
| 2021 Q2 | 105 | 39.5 M | $1.05 B |
| 2021 Q1 | 103 | 41.3 M | $1.29 B |
| 2020 Q4 | 69 | 33.1 M | $1.09 B |
| 2020 Q3 | 67 | 31.9 M | $1.11 B |